000 01465 a2200385 4500
005 20250517062737.0
264 0 _c20160629
008 201606s 0 0 eng d
022 _a1471-2407
024 7 _a10.1186/s12885-015-1915-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLohberger, Birgit
245 0 0 _aDiacerein retards cell growth of chondrosarcoma cells at the G2/M cell cycle checkpoint via cyclin B1/CDK1 and CDK2 downregulation.
_h[electronic resource]
260 _bBMC cancer
_cNov 2015
300 _a891 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnthraquinones
_xadministration & dosage
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aChondrosarcoma
_xdrug therapy
650 0 4 _aCyclin B1
_xbiosynthesis
650 0 4 _aCyclin-Dependent Kinase 2
_xbiosynthesis
650 0 4 _aG2 Phase Cell Cycle Checkpoints
_xdrug effects
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aHumans
700 1 _aLeithner, Andreas
700 1 _aStuendl, Nicole
700 1 _aKaltenegger, Heike
700 1 _aKullich, Werner
700 1 _aSteinecker-Frohnwieser, Bibiane
773 0 _tBMC cancer
_gvol. 15
_gp. 891
856 4 0 _uhttps://doi.org/10.1186/s12885-015-1915-4
_zAvailable from publisher's website
999 _c25437108
_d25437108